Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence

Low-grade, low-stage endometrioid carcinomas (LGLS EC) demonstrate 5-yr survival rates up to 95%. However, a small subset of these tumors recur, and little is known about prognostic markers or established mutation profiles associated with recurrence. The goal of the current study was to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Matrai, Cathleen E., Ohara, Kentaro, Eng, Kenneth Wha, Glynn, Shannon M., Chandra, Pooja, Chatterjee-Paer, Sudeshna, Motanagh, Samaneh, Mirabelli, Susanna, Kurtis, Boaz, He, Bing, Sigaras, Alexandros, Gupta, Divya, Chapman-Davis, Eloise, Holcomb, Kevin, Sboner, Andrea, Elemento, Olivier, Ellenson, Lora Hedrick, Mosquera, Juan Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Pathology of the Corpus: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018213/
https://www.ncbi.nlm.nih.gov/pubmed/34483300
http://dx.doi.org/10.1097/PGP.0000000000000798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018213/
https://www.ncbi.nlm.nih.gov/pubmed/34483300
http://dx.doi.org/10.1097/PGP.0000000000000798

Ejemplares similares